Authors
Latest:
2021 Acne Updates: New Drugs and ResearchA presentation from Maui Derm Live 2021 featured insights on new drugs and data in acne.
Latest:
Rashmi Sarkar, MD, FAMS: Vitiligo and StigmaSarkar spoke with Dermatology Times after the ReV conference to discuss her session on vitiligo stigma.
Latest:
Cyltezo Biosimilar Launches Today in the USBoehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.
Latest:
The JAK Inhibitor Pipeline Builds in DermatologyEight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.
Latest:
CBP/β-catenin Antagonists: A Safe and Novel Approach for Skin Rejuvenation and AgingTake a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.
Latest:
Further Research Needed to Study Link Between AD and ADHDResearchers found an association between ADHD and three inflammatory conditions—atopic dermatitis, otitis media, and herpes simplex infection.
Latest:
Roflumilast Patient Selection for Plaque Psoriasis TreatmentExperts describe roflumilast patient selection for plaque psoriasis treatment.
Latest:
Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated MelanomaNivolumab plus talazoparib did not produce RECIST-based tumor responses in heavily pretreated patients with unresectable or metastatic melanoma.
Latest:
Looking Ahead to the 2023 ACMS MeetingThe ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Latest:
Gut Microbiome Can Affect Radiation Cancer TreatmentThe overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.
Latest:
Future Directions in the Treatment of Atopic DermatitisAndrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, talk about how clinical approaches and understanding of risk/benefit profiles are evolving in light of the emerging long-term data.
Latest:
Robyn Siperstein, MD, FAAD: Initiating a Patient-First Dialogue in Cosmetic DermatologyRobyn Siperstein, MD, FAAD, reviews highlights and takeaways from her SDPA Fall 2023 sessions discussing considerations in cosmetic dermatology, thought-changing research in aesthetics, and more.
Latest:
Key Takeaways on the Management of Atopic DermatitisPanelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.
Latest:
Addressing Quality of Life Specifics Associated With Atopic Dermatitis and Skin of ColorZakiya Pressley Rice, MD, took a deep dive into how atopic dermatitis severity and increased rates of grade school absenteeism affect patients with skin of color during a recent Masterclasses in Dermatology meeting.
Latest:
Dermatologic differences in a diverse populationUnderstanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Latest:
Lloyd Miller, MD, PhD: Delving Into JNJ-2113 Data for Plaque PsoriasisMiller, Vice President, Immunodermatology Disease Area Leader, Johnson & Johnson, spoke with Dermatology Times about recently published data supporting JNJ-2113's potential in this indication.
Latest:
The Importance of Collaboration Between Mohs Surgeons and UrologistsCaleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
Latest:
Key Takeaways For the Management of Plaque PsoriasisExperts in dermatology share closing thoughts on the management of plaque psoriasis.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
Revolutionizing GPP Recognition Through Data CollectionThis Rare Disease Day, Stefan Weiss, MD, MBA, FAAD, of OM1, shares his expertise in AI’s capabilities in dermatology.
Latest:
Deucravacitinib: A Year in ReviewAs deucravacitinib surpasses its 1-year milestone since approval, clinicians continue to monitor its real-world performance among patients.
Latest:
BCC Patient Case ImpressionsSherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.
Latest:
Robert Den, MD: Exploring the Potential of Alpha DaRT in Skin CancerDen, the chief medical officer of Alpha Tau, discusses the alpha particle-emitting atom treatment and its ability to target cancer cells without harming healthy tissue.
Latest:
The Dx and Rx of Congenital Malalignment Syndrome in ChildrenCongenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Latest:
Evan Rieder, MD: Equipping Patients With Tools for Skin AcceptanceFollowing this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.
Latest:
Select Medical Software Based on Your Practice’s Life Cycle StageThough providers probably can use any type of medical software, the financial resources they are able to invest in medical solutions differ significantly based on the type of practice.
